Getting your Trinity Audio player ready...

Investors must stay alert to stocks poised for a short squeeze, given the significant gains typically seen during such events. Here’s a glimpse into five stocks potentially set for a short squeeze surge in the future.

Trump Media & Technology Corp. (NASDAQ: DJT) witnessed a stellar debut last week, followed by a more subdued performance. The short interest in DJT stock, reflecting borrowed shares anticipating a price drop, hit 4.93 million, representing 12.6% of available shares. Notably, the borrowing rate spiked to 500% due to limited shortable shares, hinting at potential short covering and a share price uptick in the future.

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is attracting attention this week for potential short squeeze dynamics. As a leading provider of innovative medical tech, it posted impressive financials for Q2 and the six months ending Dec 31, 2023, with a 114% revenue increase YoY for Q2 and 337% for the six months. This growth is tied to its Intelligent Fingerprinting Drug Screening System and global expansion. The stock hit an intraday high of $11.70 and closing high of $6.76 in 2024. This low-float stock is currently oversold, and the short interest in INBS stock surged to 57.64% in the latest report is adding intrigue to INBS’s stock movement.

Imperial Petroleum Inc. (NASDAQ: IMPP) is worth monitoring due to its significant short interest. On February 13, IMPP announced its financial results for the fourth quarter and fiscal year ending December 31, 2023. The company’s revenues for the quarter were $29.9 million, down from $37.9 million in the previous year, while net income decreased from $13.8 million to $6.5 million. However, for the full fiscal year, revenues rose by $86.7 million to reach $183.7 million compared to the previous year.

HUB Cyber Security Ltd. (NASDAQ: HUBC) is a potential stock to watch this week, given its focus on confidential computer cyber security solutions and services. On April 5, HUBC made headlines by securing $8 million in new financing through a straight debt arrangement. This strategic financing is aimed at bolstering the company’s financial position and enhancing its future prospects, as stated in the news release.

22nd Century Group Inc. (NASDAQ: XXII), a company focused on reducing nicotine harm in tobacco products, disclosed its financial performance for the quarter ending December 31, 2023, on March 28. The company reported a decrease in net revenues from $10 million to $7.4 million compared to the prior-year period. The operating loss widened from $10.2 million to $14.2 million year-over-year. Despite this, the gross profit surged from $0.1 million to $7.8 million in the same period.